In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-15 of 15 for your search:
Drug:  mercaptopurine tablet
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 0 to 75
Sponsor: Other
Protocol IDs: LPA 2005, NCT00408278

2.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and under at diagnosis
Sponsor: Other
Protocol IDs: 6-MP formulation, 2013-001236-21, NCT01906671

3.

Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to 17
Sponsor: Other
Protocol IDs: NOPHO ALL2008 consolidation, NCT00816049

4.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 1 to < 10
Sponsor: NCI, Other
Protocol IDs: AALL0932, NCI-2011-02599, CDR0000683227, U10CA098543, COG-AALL0932, NCT01190930

5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 30
Sponsor: NCI, Other
Protocol IDs: AALL1131, NCI-2011-03797, CDR0000706370, U10CA098543, COG-AALL1131, NCT01406756

6.

Phase: Phase III
Type: Behavioral study, Biomarker/Laboratory analysis, Educational/Counseling/Training
Status: Active
Age: 12 to 20
Sponsor: NCI, Other
Protocol IDs: ACCL1033, NCI-2012-00105, CDR0000721559, COG-ACCL1033, U10CA095861, NCT01503632

7.

Phase: Phase III
Type: Treatment
Status: Active
Age: 35 to 70
Sponsor: NCI
Protocol IDs: NCI-2013-02229, ECOG-E1910, E1910, U10CA021115, U10CA180820, NCT02003222

8.

Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 1 to 30
Sponsor: NCI
Protocol IDs: NCI-2014-00631, COG-AALL1331, AALL1331, U10CA098543, U10CA180886, NCT02101853

9.

Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 2 to 30
Sponsor: NCI
Protocol IDs: NCI-2014-00712, AALL1231, U10CA180886, U10CA098543, NCT02112916

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 50 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02621, CDR0000690286, CALGB-10701, CALGB 10701/CTSU C10701, U10CA031946, P30CA014236, NCT01256398

11.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: OCTO_016, NCT01432145

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: ALLR18, NCT01700946

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 65 and over
Sponsor: NCI
Protocol IDs: NCI-2014-01047, SWOG-S1318, S1318, U10CA180888, NCT02143414

14.

Phase: Phase I
Type: Treatment
Status: Approved-not yet active
Age: 51 to 75
Sponsor: Other
Protocol IDs: 14-200, NCT02228772

15.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 6 to 17
Sponsor: Other
Protocol IDs: 6-MP pharmacokinetic 1, NCT01324336
New Search